Manufacturing Chemist
  • Home
  • Categories
    • Ingredients
    • Analysis
    • Manufacturing
    • Finance
    • Company News
    • Regulatory
    • Drug Delivery
    • Research & Development
    • Sustainability
  • Pharma 5.0
  • Events
  • Directory
  • Editorial team
  • Search
    • Close search
  • Subscribe
  • Login
    • Password
      Password
      Forgot password? Close login form
  • Home
  • Company News

Company News

CellProthera appoints new board members for late-stage clinical development CellProthera appoints new board members for late-stage clinical development CellProthera appoints new board members for late-stage clinical development CellProthera, a clinical-stage biotechnology company developing regenerative cell therapies for ischemic diseases, today announced the appointment of Jérôme Hirtzlin and Anne... AES Cleanroom Technology appoints John Groth as Chief Revenue Officer AES Cleanroom Technology appoints John Groth as Chief Revenue Officer AES Cleanroom Technology appoints John Groth as Chief Revenue Officer AES Cleanroom Technology, a leading provider of modular cleanroom design, manufacturing, and construction solutions for the life sciences and biopharmaceutical industries, has... Dr. Simon Bulling joins ProBioGen as Chief Operating Officer to drive next phase of operational growth Dr. Simon Bulling joins ProBioGen as Chief Operating Officer to drive next phase of operational growth Dr. Simon Bulling joins ProBioGen as Chief Operating Officer to drive next phase of operational growth ProBioGen announced the appointment of Dr. Simon Johannes Bulling, PhD, as Chief Operating Officer (COO), effective April 15, 2026 New leadership at DWK Life Sciences: Michael Werth succeeds Armin Reiche New leadership at DWK Life Sciences: Michael Werth succeeds Armin Reiche New leadership at DWK Life Sciences: Michael Werth succeeds Armin Reiche After serving as CEO for 25 years, Armin Reiche hands operational responsibility to Michael Werth and joins the Advisory Board MasterControl appoints David Edwards as CEO to drive next phase of growth MasterControl appoints David Edwards as CEO to drive next phase of growth MasterControl appoints David Edwards as CEO to drive next phase of growth Former CEO Jon Beckstrand Appointed Chairman of the Board; Prior Chair and Salt Lake City Business Pioneer Richard Beckstrand Transitions to Board Member Quibim appoints Itta MacNevin as Chief Business Officer to accelerate global growth and life sciences partnerships Quibim appoints Itta MacNevin as Chief Business Officer to accelerate global growth and life sciences partnerships Quibim appoints Itta MacNevin as Chief Business Officer to accelerate global growth and life sciences partnerships Quibim, the global pioneer in imaging biomarkers for precision medicine, is pleased to announce the appointment of Itta MacNevin as Chief Business Officer (CBO). The... Resyca announces the appointment of Deborah Jones as CEO Resyca announces the appointment of Deborah Jones as CEO Resyca announces the appointment of Deborah Jones as CEO Dr Jones brings more than 20 years of executive leadership experience driving commercial growth in life sciences technology companies Germfree appoints Chief Executive Officer Germfree appoints Chief Executive Officer Germfree appoints Chief Executive Officer Carol Houts brings 30 years of healthcare and life sciences leadership to Germfree’s next phase of growth and execution Saharsh Davuluri to take over as CEO & MD of Neuland and lead the next phase of CDMO expansion Saharsh Davuluri to take over as CEO & MD of Neuland and lead the next phase of CDMO expansion Saharsh Davuluri to take over as CEO & MD of Neuland and lead the next phase of CDMO expansion Announcement follows several years of stellar growth and points to a sharper focus on expanding commercial NCE opportunities Sygnature Discovery strengthens in vivo pharmacology leadership with appointment of Susanne Back Sygnature Discovery strengthens in vivo pharmacology leadership with appointment of Susanne Back Sygnature Discovery strengthens in vivo pharmacology leadership with appointment of Susanne Back The appointment of Susanne Back as Head of In Vivo Pharmacology will further strengthen its bioscience leadership and reinforcing its commitment to delivering high-quality,... BioDuro appoints Dr. Andrew Thomas and Dr. Stevan Djuric as Scientific Advisors BioDuro appoints Dr. Andrew Thomas and Dr. Stevan Djuric as Scientific Advisors BioDuro appoints Dr. Andrew Thomas and Dr. Stevan Djuric as Scientific Advisors Industry leaders bring decades of pharmaceutical R&D leadership to support BioDuro’s global innovation and clients’ programs FUJIFILM Biotechnologies Appoints Christiane Bardroff as Chief Business Officer FUJIFILM Biotechnologies Appoints Christiane Bardroff as Chief Business Officer FUJIFILM Biotechnologies Appoints Christiane Bardroff as Chief Business Officer FUJIFILM Biotechnologies, a world-leading contract development and manufacturing organisation (CDMO) for biologics, vaccines, and advanced therapies, announced the appointment... Envair Technology appoints new sales director to accelerate global growth Envair Technology appoints new sales director to accelerate global growth Envair Technology appoints new sales director to accelerate global growth Orders up 20% year on year as demand for clean air solutions increases across higher education, pharma and healthcare sectors Kindeva appoints Mike Cowhig as Chief Legal Officer Kindeva appoints Mike Cowhig as Chief Legal Officer Kindeva appoints Mike Cowhig as Chief Legal Officer The appointment will drive legal strategy, enterprise risk management and corporate governance across the organisation EyeC enters Brazilian market with first-time exhibition at ExpoPrint & ConverFlexo EyeC enters Brazilian market with first-time exhibition at ExpoPrint & ConverFlexo EyeC enters Brazilian market with first-time exhibition at ExpoPrint & ConverFlexo Appointment of local regional manager strengthens support for Latin America’s print and packaging industry OSE Immunotherapeutics confirms Marc Le Bozec as chief executive officer OSE Immunotherapeutics confirms Marc Le Bozec as chief executive officer OSE Immunotherapeutics confirms Marc Le Bozec as chief executive officer Le Bozec to lead next phase of strategic growth and accelerate patient access to breakthrough therapies
  • Previous
  • 1
  • 2
  • 3 (current)
  • 4
  • 5
  • 6
  • 7
  • …
  • 215
  • Next

Trending Articles

  1. FUJIFILM Biotechnologies transitions leadership to drive next phase of operational excellence FUJIFILM Biotechnologies today announced a planned leadership evolution as the Company enters its next phase of execution and sustainable growth
  2. Simris Group appoints biotechnology expert Dr. Tiffany J. Vora as strategic advisor Appointment strengthens Simris Group's engagement with the US biotechnology ecosystem and supports advancement of its ADC platform
  3. Actimed strengthens board with appointment of Dr Anders Ullman Pharmaceutical executive brings more than 30 years of international drug development and corporate leadership experience
  4. Fresenius Medical Care appoints Cassie McLean as Management Board member for Care Delivery Cassie McLean succeeds Craig Cordola as CEO of Care Delivery, effective 1 August 2026
  5. Clinilabs announces medical leadership appointments Bob Dagher, M.D., named chief medical officer and Waqar Ahmed Siddiqui, M.D., named principal investigator

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy
See all

Become a Subscriber

Subscribe now Already a subscriber? Sign in here. Find out more

Get our newsletter

Follow us

  • LinkedIn
  • About Manufacturing Chemist
  • About HPCi Media
  • Newsletter sign up
  • Contact Us
  • Advertise
  • Terms and Conditions
  • Privacy
© HPCi Media Limited | Registered in England No. 06716035 | VAT GB 939828072 | a Claverley Group company Registered office address:
One Anchorage Avenue,
Shrewsbury Business Park,
Shrewsbury,
SY2 6FG, UK.